At Topos Bio, we're pioneering drug discovery for intrinsically disordered proteins—targets that have eluded conventional approaches in neurodegeneration, oncology, and cardiometabolic disease.
We're seeking a cell biologist to develop and execute cell-based assays for validating computational predictions and supporting medicinal chemistry efforts. You'll work at the interface of disease biology, protein biophysics, and drug screening.
What you will doDevelop and optimize mammalian cell-based assays for disordered protein targets
Execute phenotypic and reporter-based screening campaigns to validate computational hits
Characterize compound activity and support structure-activity relationship studies
Collaborate with computational scientists to integrate experimental data with modeling workflows
Establish robust assay protocols and quality control metrics
Strong foundation in mammalian cell culture and cellular assay development
Experience with disease-relevant cellular models
Ability to troubleshoot complex biological systems and optimize experimental protocols
Track record of productivity and effective collaboration
PhD in cell and molecular biology with focus on disease models
Industry experience in drug discovery or biotech
Experience with reporter assays and high-throughput screening platforms
Familiarity with oncology, neurodegeneration, or metabolic disease models
Track record of developing novel cellular assays or screening approaches
Similar Jobs
What you need to know about the San Francisco Tech Scene
Key Facts About San Francisco Tech
- Number of Tech Workers: 365,500; 13.9% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Google, Apple, Salesforce, Meta
- Key Industries: Artificial intelligence, cloud computing, fintech, consumer technology, software
- Funding Landscape: $50.5 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Sequoia Capital, Andreessen Horowitz, Bessemer Venture Partners, Greylock Partners, Khosla Ventures, Kleiner Perkins
- Research Centers and Universities: Stanford University; University of California, Berkeley; University of San Francisco; Santa Clara University; Ames Research Center; Center for AI Safety; California Institute for Regenerative Medicine



